Medical affairs teams need a comprehensive, current, and cross-geography view of the scientific and clinical landscape, not as a periodic research project, but as an ongoing capability they can draw on every day. Literature accumulates faster than any team can manually track, trials read out on their own timelines, and competitors publish evidence that shapes the conversation before your team even sees it. Dr. Evidence is the medical affairs platform built to keep pace: one system for literature intelligence, clinical trial monitoring, and field enablement, all grounded in verified, source-cited data.
Medical affairs leads use Dr. Evidence to shape evidence generation strategy from a complete view of the current scientific landscape, rather than a partial one assembled under deadline pressure. Medical Science Liaisons rely on the platform for field intelligence and scientific exchange, walking into conversations with the latest data already in hand. Clinical operations teams use it to monitor the broader trial landscape and anticipate how competitive programs are progressing. And HEOR teams draw on the same intelligence to strengthen real-world evidence generation and outcomes research.
Book a DemoTraditional medical literature search means keyword searches across siloed databases, followed by hours of manual synthesis just to understand what the literature actually says. Dr. Evidence's AI-powered medical literature search works differently: it synthesizes findings across a vast, regularly updated body of scientific literature, surfacing what's relevant with a speed and precision manual review can't match. Every result stays connected to its source, so your team can trust what it's building on. Combined with regular monitoring, this isn't a one-time literature search. It's an always-updated view of the scientific landscape your team can return to as often as strategy requires. As one of the more effective AI tools for medical literature search available to medical affairs teams, it replaces days of manual review with an answer your team can act on immediately.
Staying ahead of a competitive landscape means knowing what's happening in trials long before topline results are public. Dr. Evidence provides pharma clinical trials intelligence that monitors pipeline activity and trial outcomes across the field, giving your evidence generation strategy the context it needs to anticipate competitive data readouts rather than react to them after publication. For biopharma clinical trials intelligence teams building out their own evidence plans, understanding where the broader landscape is heading is just as important as understanding their own program's data.
An MSL walking into a scientific exchange is only as effective as the intelligence behind them. Dr. Evidence equips field teams with a current view of the competitive landscape, the most recent label changes relevant to their therapeutic area, and the scientific talking points that matter in that specific conversation. Instead of relying on static leave-behinds or last quarter's briefing document, MSLs draw on the same regularly updated intelligence the rest of the organization uses, which means every scientific exchange reflects where the landscape stands today, not where it stood at the last training cycle.
Medical affairs doesn't operate in isolation, and neither should its intelligence. Dr. Evidence functions as the bridge between regulatory, medical affairs, and clinical operations teams, giving all three a single authoritative source instead of three separate research efforts arriving at three different answers. That shared foundation eliminates duplicated work, keeps cross-functional conversations grounded in the same evidence, and means insights discovered by one team don't have to be rediscovered by another.
Medical affairs teams that work from up-to-date, verified intelligence make faster, more confident decisions, from evidence generation to field enablement.
Book a Demo to see Dr. Evidence's pharma labeling software in action to see exactly how it works.